Digitek Recall: Drug Used To Treat Heart Conditions May Have Double The Dose

The FDA recently announced a Class I recall of all Digitek tablets, which may contain twice the approved level of Digoxin. Digitek is a drug used in the treatment of heart failure and abnormal heart rhythms, the double strength of the pill may actually increase the risk of heart attacks and possibly death in patients who use the drug.

Actavis Totowa LLC, a U.S. manufacturing division of the international generic pharmaceutical company Actavis Group, notified healthcare professionals of a Class I nationwide recall of all strengths of Digitek (also known as Digoxin). The recall is due to the possibility that tablets with double the appropriate thickness - therefore double the dose of Digoxin - may have been commercially released. In announcing the recall, Actavis said the double-strength tablets pose a risk of toxicity in patients with renal failure. The right amount of Digoxin can strengthen a weak heart and calm abnormal heartbeats. Too much Digoxin can make you nauseous, depress your blood pressure, slow down your heart rate or even lead to death. The drug is distributed by Mylan Pharmaceuticals under a Bertek label and by UDL Laboratories under a UDL label. Pharmacies are being asked to check their records for patients who took it as far back as March of 2006.

Heath Risks and Symptoms:

• Vomiting
• Nausea
• Dizziness
• Low blood pressure
• Cardiac instability
• Abnormal heart beat

If you or a loved one have experienced any serious side effects associated with your use of Digitek, you are urged to seek medical attention. It may also be important to contact an attorney who can help you protect your potential legal claim. If you would like more information, or would just like to talk with a lawyer experienced in this litigation, please call attorney Stacy Hauer at 1.800.755.0098 for a free consultation or click below to fill out a free case review form.